Apellis Pharmaceuticals

Home » Apellis Pharmaceuticals

IPO

Apellis Pharmaceuticals

They are a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutic compounds for autoimmune and inflammatory diseases.

Symbol

APLS

Price Range
TBD

Anticipated Shares
10,000,000

Effective Date
November 9, 2017

Underwriters
Citigroup, J.P. Morgan, Evercore ISI

To view the prospectus for Apellis Pharmaceuticals IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253